Hong Kong S.a.r.
Fleming MedLab is a medical robotics startup that specializes in stroke rehabilitation and gait training, offering wearable robotics for stroke survivors. The company's slogan "Training patients on gait recovery and neurorehabilitation" encapsulates its core mission.
Founded in 2022 and headquartered in Hong Kong S.a.r., Fleming MedLab's interdisciplinary team, comprising members from Engineering, Physics, Neuroscience, and Rehab Science backgrounds, collaborates closely with hospitals, rehab centers, and professional clinics to provide early-stage stroke patients with advanced treatment.
The company's focus on designing medical-grade robots with patented technology and neuroscience principles sets it apart. Through a combination of data intelligence and biomechanics data, Fleming MedLab equips therapists with valuable insights for tailored therapy advice.
With an ambition to restore patients to pre-stroke mobility and independence using their wearable exoskeletons, Fleming MedLab emphasizes that stroke recovery is only halfway, with the ultimate goal being a return to full life participation.
Though Fleming MedLab has not disclosed its last investment or the respective investors, it operates within the Health Care and Robotics industries, positioning itself at the intersection of technological innovation and healthcare advancement.
